What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s free cash flow yield?

Over 3 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s free cash flow yield has grown at a 82.8% compound annual growth rate (CAGR), from 2.5% to -15%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Maravai LifeSciences Holdings, Inc. MRVI Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher ScientificTMO

3.7%+0.1pp

DanaherDHR

3.9%+0.6pp

RepligenRGEN

1.6%-0.1pp

ADMA BiologicsADMA

5%+3.1pp

RevvityRVTY

5%+0.9pp

TEC

Bio-TechneTECH

3.3%+0.9pp

Other financials

Income statement

See full

Revenue$65.8M+40.5%

Gross profit$33.7M+336%

Operating income-$2.2M+95.6%

Net income-$3.7M+87.5%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$165.9M-41.8%

Total debt$270.9M-17.1%

Total equity$211.6M-29.6%

Total assets$713.2M-25.7%

Cash flow

See full

Operating cash flow$8.7M+192%

CapEx$4.4M-1.4%

Free cash flow$4.2M+130%

Valuation

See full

Market cap$849.64M+204%

Enterprise value$954.59M+198%

P/S4.2×+3.0×

Profitability

See full

Gross margin29.3%-8.0pp

Operating margin-82.2%-16.6pp

Net margin-51.1%-9.9pp

FCF margin-25.7%—

Returns & leverage

See full

Return on equity-40.8%-4.0pp

Debt / equity1.3×+0.2×

Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

free cash flow/market cap=-12.7%

Based on trailing twelve months.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s free cash flow yield?: Maravai LifeSciences Holdings, Inc. (MRVI) reported free cash flow yield of -12.7% in Q1 2026.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s free cash flow yield?: Over 3 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s free cash flow yield has grown at a 82.8% compound annual growth rate (CAGR), from 2.5% to -15%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.